News | RIVM

Fewer coronavirus infections among people who kept distancing

People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.

Coronavirus monitoring in sewage research expanded and extended

Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.

Werkbezoek Hugo de Jonge aan een rioolwaterzuiveringsinstallatie in Leiden

Situation growing worse in the Netherlands

In the week from 17 to 23 March, 46,005 people received a positive test result for COVID-19, an increase of 16% compared to the week before that. The reproduction number continued to rise, from 1.06 on 1 March to 1.11 on 8 March.

Number of positive COVID-19 tests at the same level as last week

In the week from 2 to 9 March, 31,959 people received a positive test result for COVID-19, about the same as in the week before that. More than 360,000 people were tested, an increase of nearly 14% compared to the week before that.

Policy on coronavirus measures causes friction, but compliance is still high for now

Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.

First clients and care workers in mental healthcare vaccinated on Monday

The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.

New research in GGD test lanes on spread of coronavirus SARS-CoV-2

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.

New variants disrupt plans

In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.

One person died shortly after COVID-19 vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

Nationwide assessment of SARS-CoV-2 laboratories: very high quality

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.